A Nanostructured Protein Filtration Device for Possible Use in the Treatment of Alzheimer’s Disease—Concept and Feasibility after In Vivo Tests

Background: Alzheimer’s disease (AD), along with other neurodegenerative disorders, remains a challenge for clinicians, mainly because of the incomplete knowledge surrounding its etiology and inefficient therapeutic options. Considering the central role of amyloid beta (Aβ) in the onset and evolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiner, Thomas Gabriel, Menéndez-González, Manuel, Adam, Maricel, Popescu, Bogdan Ovidiu, Szilagyi, Andrei, Stanciu, Gabriela Dumitrita, Tamba, Bogdan Ionel, Ciobanu, Romeo Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669467/
https://www.ncbi.nlm.nih.gov/pubmed/38002427
http://dx.doi.org/10.3390/bioengineering10111303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669467/
https://www.ncbi.nlm.nih.gov/pubmed/38002427
http://dx.doi.org/10.3390/bioengineering10111303

Ejemplares similares